ARCHIVES

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

This article is from The Cancer Letter archive.

Vol. 20 No. 16 | April 22, 1994

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Biomarker Test Outperforms PSA and Gleason Score in Study

July 26, 2013

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

In Brief: Cowan to Direct Eppley Cancer Center; Nealon Retires From NCI Liaison Office

June 11, 1999

Pennsylvania House Approves Bills Establishing Control, Research Funds With Cigarette Tax

August 11, 1978